Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

Heintz Discusses Dysregulation of Redox Signaling in Cancer Cells on PLoS Science Wednesday

January 20, 2016 by Brittany Willette

Nicholas Heintz, Ph.D., UVM professor of pathology, and colleagues were featured in a PLoS Science Wednesday live “Ask Me Anything” chat on redditscience, discussing a recently published study focusing on dysregulation of redox signaling in cancer cells, and how the enhanced production of reactive oxygen species (ROS) in tumor cell mitochondria can be exploited for therapeutic purposes in aggressive human malignancies like mesothelioma. Read the full transcript of the chat here.

UVM Professor of Pathology Nicholas Heintz, Ph.D. (Photo: COM Design & Photography)

(JANUARY 20, 2016)  Nicholas Heintz, Ph.D., UVM professor of pathology, and colleagues were featured in a PLoS Science Wednesday live “Ask Me Anything” chat on redditscience, discussing a recently published study focusing on dysregulation of redox signaling in cancer cells, and how the enhanced production of reactive oxygen species (ROS) in tumor cell mitochondria can be exploited for therapeutic purposes in aggressive human malignancies like mesothelioma. Read the full transcript of the chat here.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!